Suxia Liu

Title: Suxia Liu: Innovator in Anti-Cancer Therapeutics

Introduction

Suxia Liu is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of anti-cancer therapeutics. His innovative work has led to the creation of a patent that holds promise for treating various diseases.

Latest Patents

Suxia Liu holds a patent for an "Anti-B7-H4 antibody, antigen-binding fragment thereof and pharmaceutical use thereof." This invention includes a chimeric antibody and a humanized antibody that comprises a CDR region of the anti-B7-H4 antibody. The patent also details a pharmaceutical composition that includes the anti-B7-H4 antibody and its antigen-binding fragment, which can be used as an anti-cancer medicament. Furthermore, it describes the use of a humanized anti-B7-H4 antibody in preparing a medicament for treating diseases mediated by B7-H4. Liu's patent is a significant advancement in the fight against cancer.

Career Highlights

Throughout his career, Suxia Liu has worked with notable companies in the pharmaceutical industry. He has been associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Suxia Liu has collaborated with esteemed colleagues in his field, including Rudi Bao and Haiqing Hua. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical technologies.

Conclusion

Suxia Liu's contributions to the field of anti-cancer therapeutics through his innovative patent demonstrate his commitment to advancing medical science. His work not only showcases his expertise but also holds the potential to impact the treatment of cancer significantly.